Cannabis

We must seriously consider decriminalisation for patients unable to access cannabis-based medicines on the NHS

We must seriously consider decriminalisation for patients unable to access cannabis-based medicines on the NHS

David King, Senior Researcher

The draft NICE guidelines for the use of Cannabis-based medicinal products (CBMPs), which were published last week, contained no recommendations for the use of CBMPs except nabilone as an add-on treatment for adults suffering from intractable nausea and vomiting. Thus, for now, prescriptions of CBMPs on the NHS are likely to remain effectively unavailable. That these guidelines were highly restrictive and risk-averse came as no surprise to most, but nonetheless a huge disappointment for many.

Let’s end the harms of cannabis prohibition

Let’s end the harms of cannabis prohibition

Viewpoint by Andrew Boff AM

At heart, I’m a libertarian - I believe that people should be free to make their own choices. But drugs reform is more than this. It’s about safety and protecting people from harm - a harm of government making.

Cannabis is out there and people are using it - to say that criminalisation is working is borderline delusional. The government’s own data shows that 30 per cent of 16 to 59-year olds in England and Wales have smoked cannabis. This is slightly higher for 16 to 24-year olds, at 30.7 per cent, which suggests usage is rising. Much of this will be provided by the black market - drug dealers don’t have age restrictions or product standards.